Canlyniadau Chwilio - Kabbinavar, Fairooz

HBI-8000, HUYABIO Lead Clinical Program, Is a Selective Histone Deacetylase Inhibitor With Therapeutic Benefits in Leukemia and in Solid Tumors gan Shojaei, Farbod, Goodenow, Bob, Lee, Gloria, Kabbinavar, Fairooz, Gillings, Mireille

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies gan Cassidy, James, Saltz, Leonard B., Giantonio, Bruce J., Kabbinavar, Fairooz F., Hurwitz, Herbert I., Rohr, Ulrich-Peter

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Dacomitinib, an Irreversible Pan-ErbB Inhibitor Significantly Abrogates Growth in Head and Neck Cancer Models That Exhibit Low Response to Cetuximab gan Ather, Ferdows, Hamidi, Habib, Fejzo, Marlena S., Letrent, Stephen, Finn, Richard S., Kabbinavar, Fairooz, Head, Christian, Wong, Steven G.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A randomized Phase II trial of the tumor vascular disrupting agent CA4P (fosbretabulin tromethamine) with carboplatin, paclitaxel, and bevacizumab in advanced nonsquamous non-small... gan Garon, Edward B, Neidhart, Jeffrey D, Gabrail, Nashat Y, de Oliveira, Moacyr R, Balkissoon, Jai, Kabbinavar, Fairooz

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Efficacy and Safety of Bevacizumab in Metastatic Colorectal Cancer: Pooled Analysis From Seven Randomized Controlled Trials gan Hurwitz, Herbert I., Tebbutt, Niall C., Kabbinavar, Fairooz, Giantonio, Bruce J., Guan, Zhong-Zhen, Mitchell, Lada, Waterkamp, Daniel, Tabernero, Josep

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Systemic Therapy for Metastatic Renal Cell Carcinoma: A Review and Update gan Logan, Joshua E, Rampersaud, Edward N, Sonn, Geoffrey A, Chamie, Karim, Belldegrun, Arie S, Pantuck, Allan J, Slamon, Dennis J, Kabbinavar, Fairooz F

Cael y testun llawn Cael y testun llawn

Histologic Evaluation of Metastases in Renal Cell Carcinoma With Sarcomatoid Transformation and Its Implications for Systemic Therapy gan Shuch, Brian, Said, Jonathan, LaRochelle, Jeffrey C., Zhou, Ying, Li, Gang, Klatte, Tobias, Pouliot, Frederic, Kabbinavar, Fairooz F., Belldegrun, Arie S., Pantuck, Allan J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A Randomized, Phase II, Biomarker-Selected Study Comparing Erlotinib to Erlotinib Intercalated With Chemotherapy in First-Line Therapy for Advanced Non–Small-Cell Lung Cancer gan Hirsch, Fred R., Kabbinavar, Fairooz, Eisen, Tim, Martins, Renato, Schnell, Fredrick M., Dziadziuszko, Rafal, Richardson, Katherine, Richardson, Frank, Wacker, Bret, Sternberg, David W., Rusk, Jason, Franklin, Wilbur A., Varella-Garcia, Marileila, Bunn, Paul A., Camidge, D. Ross

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial gan Herbst, Roy S, Sun, Yan, Eberhardt, Wilfried E E, Germonpré, Paul, Saijo, Nagahiro, Zhou, Caicun, Wang, Jie, Li, Longyun, Kabbinavar, Fairooz, Ichinose, Yukito, Qin, Shukui, Zhang, Li, Biesma, Bonne, Heymach, John V, Langmuir, Peter, Kennedy, Sarah J, Tada, Hiroomi, Johnson, Bruce E

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer gan Garon, Edward B., Christofk, Heather R., Hosmer, Wylie, Britten, Carolyn D, Bahng, Agnes, Crabtree, Matthew J, Hong, Candice Sun, Kamranpour, Naeimeh, Pitts, Sharon, Kabbinavar, Fairooz, Patel, Cecil, von Euw, Erika, Black, Alexander, Michelakis, Evangelos D., Dubinett, Steven M., Slamon, Dennis J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Dendritic Cell-Based Immunotherapy in Prevention and Treatment of Renal Cell Carcinoma: Efficacy, Safety, and Activity of Ad-GM∙CAIX in Immunocompetent Mouse Models gan Birkhäuser, Frédéric D, Koya, Richard C, Neufeld, Caleb, Rampersaud, Edward N, Lu, Xuyang, Micewicz, Ewa D, Chodon, Thinle, Atefi, Mohammad, Kroeger, Nils, Chandramouli, Gadisetti VR, Li, Gang, Said, Jonathan W, McBride, William H, Kabbinavar, Fairooz F, Ribas, Antoni, Pantuck, Allan J, Belldegrun, Arie S, Riss, Joseph

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial gan Hurvitz, Sara A., Saura, Cristina, Oliveira, Mafalda, Trudeau, Maureen E., Moy, Beverly, Delaloge, Suzette, Gradishar, William, Kim, Sung‐Bae, Haley, Barbara, Ryvo, Larisa, Dai, Ming‐Shen, Milovanov, Vladimir, Alarcón, Jesús, Kalmadi, Sujith, Cronemberger, Eduardo, Souza, Cristiano, Landeiro, Luciana, Bose, Ron, Bebchuk, Judith, Kabbinavar, Fairooz, Bryce, Richard, Keyvanjah, Kiana, Brufsky, Adam M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial gan Rittmeyer, Achim, Barlesi, Fabrice, Waterkamp, Daniel, Park, Keunchil, Ciardiello, Fortunato, von Pawel, Joachim, Gadgeel, Shirish M, Hida, Toyoaki, Kowalski, Dariusz M, Dols, Manuel Cobo, Cortinovis, Diego L, Leach, Joseph, Polikoff, Jonathan, Barrios, Carlos, Kabbinavar, Fairooz, Frontera, Osvaldo Arén, De Marinis, Filippo, Turna, Hande, Lee, Jong-Seok, Ballinger, Marcus, Kowanetz, Marcin, He, Pei, Chen, Daniel S, Sandler, Alan, Gandara, David R

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma: A Random... gan Cloughesy, Timothy F., Petrecca, Kevin, Walbert, Tobias, Butowski, Nicholas, Salacz, Michael, Perry, James, Damek, Denise, Bota, Daniela, Bettegowda, Chetan, Zhu, Jay-Jiguang, Iwamoto, Fabio, Placantonakis, Dimitris, Kim, Lyndon, Elder, Brad, Kaptain, George, Cachia, David, Moshel, Yaron, Brem, Steven, Piccioni, David, Landolfi, Joseph, Chen, Clark C., Gruber, Harry, Rao, Aliz R., Hogan, Daniel, Accomando, William, Ostertag, Derek, Montellano, Tiffany T., Kheoh, Thian, Kabbinavar, Fairooz, Vogelbaum, Michael A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findin... gan Shi, Qian, de Gramont, Aimery, Grothey, Axel, Zalcberg, John, Chibaudel, Benoist, Schmoll, Hans-Joachim, Seymour, Matthew T., Adams, Richard, Saltz, Leonard, Goldberg, Richard M., Punt, Cornelis J.A., Douillard, Jean-Yves, Hoff, Paulo M., Hecht, Joel Randolph, Hurwitz, Herbert, Díaz-Rubio, Eduardo, Porschen, Rainer, Tebbutt, Niall C., Fuchs, Charles, Souglakos, John, Falcone, Alfredo, Tournigand, Christophe, Kabbinavar, Fairooz F., Heinemann, Volker, Van Cutsem, Eric, Bokemeyer, Carsten, Buyse, Marc, Sargent, Daniel J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database... gan Renfro, Lindsay A., Goldberg, Richard M., Grothey, Axel, Sobrero, Alberto, Adams, Richard, Seymour, Matthew T., Heinemann, Volker, Schmoll, Hans-Joachim, Douillard, Jean-Yves, Hurwitz, Herbert, Fuchs, Charles S., Diaz-Rubio, Eduardo, Porschen, Rainer, Tournigand, Christophe, Chibaudel, Benoist, Hoff, Paulo M., Kabbinavar, Fairooz F., Falcone, Alfredo, Tebbutt, Niall C., Punt, Cornelis J.A., Hecht, J. Randolph, Souglakos, John, Bokemeyer, Carsten, Van Cutsem, Eric, Saltz, Leonard, de Gramont, Aimery, Sargent, Daniel J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Evaluation of Continuous Tumor-Size–Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer gan Burzykowski, Tomasz, Coart, Elisabeth, Saad, Everardo D., Shi, Qian, Sommeijer, Dirkje W., Bokemeyer, Carsten, Díaz-Rubio, Eduardo, Douillard, Jean-Yves, Falcone, Alfredo, Fuchs, Charles S., Goldberg, Richard M., Hecht, J. Randolph, Hoff, Paulo M., Hurwitz, Herbert, Kabbinavar, Fairooz F., Koopman, Miriam, Maughan, Timothy S., Punt, Cornelis J. A., Saltz, Leonard, Schmoll, Hans-Joachim, Seymour, Matthew T., Tebbutt, Niall C., Tournigand, Christophe, Van Cutsem, Eric, de Gramont, Aimery, Zalcberg, John R., Buyse, Marc

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis gan Yin, Jun, Dawood, Shaheenah, Cohen, Romain, Meyers, Jeff, Zalcberg, John, Yoshino, Takayuki, Seymour, Matthew, Maughan, Tim, Saltz, Leonard, Van Cutsem, Eric, Venook, Alan, Schmoll, Hans-Joachim, Goldberg, Richard, Hoff, Paulo, Hecht, J. Randolph, Hurwitz, Herbert, Punt, Cornelis, Diaz Rubio, Eduard, Koopman, Miriam, Cremolini, Chiara, Heinemann, Volker, Tournigard, Christophe, Bokemeyer, Carsten, Fuchs, Charles, Tebbutt, Niall, Souglakos, John, Doulliard, Jean-Yves, Kabbinavar, Fairooz, Chibaudel, Benoist, de Gramont, Aimery, Shi, Qian, Grothey, Axel, Adams, Richard

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The High-Dose Aldesleukin “Select” Trial: A Trial to Prospectively Validate Predictive Models of Response Treatment in Patients with Metastatic Renal Cell Carcinoma gan McDermott, David F., Cheng, Su-Chun, Signoretti, Sabina, Margolin, Kim A., Clark, Joseph I., Sosman, Jeffrey A., Dutcher, Janice P., Logan, Theodore F., Curti, Brendan D., Ernstoff, Marc S., Appleman, Leonard, Wong, Michael K.K., Khushalani, Nikhil I., Oleksowicz, Leslie, Vaishampayan, Ulka N., Mier, James W., Panka, David J., Bhatt, Rupal S., Bailey, Alexandra S., Leibovich, Bradley C., Kwon, Eugene D., Kabbinavar, Fairooz F., Belldegrun, Arie S., Figlin, Robert A., Pantuck, Allan J., Regan, Meredith M., Atkins, Michael B.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project gan Sjoquist, Katrin M, Renfro, Lindsay A, Simes, R John, Tebbutt, Niall C, Clarke, Stephen, Seymour, Matthew T, Adams, Richard, Maughan, Timothy S, Saltz, Leonard, Goldberg, Richard M, Schmoll, Hans-Joachim, Van Cutsem, Eric, Douillard, Jean-Yves, Hoff, Paulo M, Hecht, Joel Randolph, Tournigand, Christophe, Punt, Cornelis J A, Koopman, Miriam, Hurwitz, Herbert, Heinemann, Volker, Falcone, Alfredo, Porschen, Rainer, Fuchs, Charles, Diaz-Rubio, Eduardo, Aranda, Enrique, Bokemeyer, Carsten, Souglakos, Ioannis, Kabbinavar, Fairooz F, Chibaudel, Benoist, Meyers, Jeffrey P, Sargent, Daniel J, de Gramont, Aimery, Zalcberg, John R

Cael y testun llawn Cael y testun llawn Cael y testun llawn